Filip Krag Knop

Filip Krag Knop

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


Publication year:
All
21 - 30 out of 37Page size: 10
Sort by: 1st author
  1. Published

    Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: a systematic review and meta-analysis

    Rohde, U., Hedbäck, N., Gluud, Lise Lotte, Vilsbøll, Tina & Knop, Filip Krag, Mar 2016, In: Diabetes, Obesity and Metabolism. 18, 3, p. 300-5 6 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  2. Published

    Cholecystokinin-Induced Gallbladder Emptying and Single-Dose Metformin Elicit Additive Glucagon-Like Peptide-1 Responses

    Rohde, U., Sonne, D. P., Christensen, M., Hansen, M., Brønden, A., Toräng, S., Rehfeld, Jens Frederik, Holst, Jens Juul, Vilsbøll, Tina & Knop, Filip Krag, 1 May 2016, In: The Journal of clinical endocrinology and metabolism. 101, 5, p. 2076-2083

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Sodium-glucose cotransporter 2 (SGLT-2) inhibitors for patients with Type 2 diabetes

    Røder, M. E., Storgaard, H., Rungby, Jørgen, Knop, Filip Krag & Vilsbøll, Tina, 19 Sep 2016, In: Ugeskrift for Laeger. 178, 38

    Research output: Contribution to journal › Review › Research › peer-review

  4. Published

    Sodium-glucose cotransporter (SGLT)-2-inhibitorer til patienter med type 2-diabetes

    Røder, M. E., Storgaard, H., Rungby, J., Knop, Filip Krag & Vilsbøll, Tina, 26 Dec 2016, In: Ugeskrift for Laeger. 178, 26, p. 2461-64 V05160310.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Sodium-glucose cotransporter 2 (SGLT-2) inhibitors for patients with Type 2 diabetes

    Røder, M. E., Storgaard, H., Rungby, Jørgen, Knop, Filip Krag & Vilsbøll, Tina, 19 Sep 2016, In: Ugeskrift for Laeger. 178, 38

    Research output: Contribution to journal › Review › Research › peer-review

  6. Published

    Diabetes and obesity treatment based on dual incretin receptor activation: ‘twincretins’

    Skow, M. A., Bergmann, N. C. & Knop, Filip Krag, Sep 2016, In: Diabetes, Obesity and Metabolism. 18, 9, p. 847-54 8 p.

    Research output: Contribution to journal › Review › Research › peer-review

  7. Published

    Postprandial Plasma Concentrations of Individual Bile Acids and FGF-19 in Patients With Type 2 Diabetes

    Sonne, David Peick, van Nierop, F. S., Kulik, W., Soeters, M. R., Vilsbøll, Tina & Knop, Filip Krag, Aug 2016, In: Endocrinology. 101, 8, p. 3002-3009 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Species-specific action of (Pro3)GIP - an efficacious agonist on human GIP receptor, but partial agonist and competitive antagonist on rat and mouse GIP receptors

    wbf943, wbf943, Gasbjerg, Lærke Smidt, Svendsen, B., Christensen, M., Knop, Filip Krag, Hartmann, Bolette, Holst, Jens Juul & Rosenkilde, Mette, Jan 2016, In: British Journal of Pharmacology. 173, 1, p. 27-38 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Vagotomy and subsequent development of diabetes: A nested case-control study

    Starup-Linde, J., Gejl, M., Borghammer, P., Knop, Filip Krag, Gregersen, S., Rungby, Jørgen & Vestergaard, P., Jul 2016, In: Metabolism. 65, 7, p. 954-960 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis

    Storgaard, H., Gluud, Lise Lotte, Bennett, C., Grøndahl, M. F., Christensen, Mikkel Bring, Knop, Filip Krag & Vilsbøll, Tina, 2016, In: PLOS ONE. 11, 11, 23 p., e0166125.

    Research output: Contribution to journal › Review › Research › peer-review

Previous 1 2 3 4 Next

ID: 40100368